Powerful Medical, Bratislava (2025)

01/08/2025

We are thrilled to announce that Powerful Medical has been selected to receive over €40 million in non-dilutive grant funding through the European Commission’s IPCEI Tech4Cure initiative – one of the largest EU grants awarded to a healthcare technology company to date.

This milestone accelerates our mission to transform global cardiovascular care through ®, the world’s first AI-powered platform for rapid and accurate cardiovascular diagnostics.

Why it matters:

• Cardiovascular disease remains the #1 cause of death worldwide, with heart attacks accounting for the majority of these fatalities.

• In just the first half of 2025, PMcardio helped detect over 36,000 heart attacks, saving more than 1,000 lives.

• PMcardio identifies heart attacks with twice the sensitivity and up to 3 hours earlier than the current standard of care.

• Its ability to deliver precise, real-time diagnosis at the first point of contact improves outcomes in acute care, where timely intervention is critical.

The secured IPCEI funding highlights the real-world impact of our work and its potential to significantly reduce the burden of cardiovascular diseases on a global scale.

It will enable us to accelerate the development of new AI models and expand PMcardio’s reach across healthcare systems around the world, backed by prospective randomized controlled trials to ensure the highest level of clinical excellence.

A special thank you to our early investors — Zero One Hundred, LifeX Ventures, and Venture to Future Fund — for their continued support and trust in our vision. We’d also like to thank the incredible team at EY for supporting us through the IPCEI grant process.

Full press release here: https://eu1.hubs.ly/H0m6Gly0

29/07/2025

🔥 Published this month: Three NEW external validation studies all point to one conclusion: AI can detect acute coronary occlusion where contemporary ECG criteria fail!

Here’s what the latest research reveals:

1️⃣ Coronary Artery Disease Journal: “AI-enhanced recognition of occlusions in ACS (AERO-ACS)”
➤ AI has 100% sensitivity for STEMI detection
➤ STEMI equivalent patients experienced 12x longer delays to treatment (15.4 hrs vs. 1.3 hrs)
➤ AI-detected OMI strongly correlated with higher in-hospital mortality

🩺 Two publications in the latest issue of European Heart Journal – Acute Cardiovascular Care, accompanied by an editorial that highlights the need to shift from the STEMI/NSTEMI paradigm toward the more precise OMI/Non-OMI model:

2️⃣ “Failure of standard STEMI ECG criteria to detect LAD occlusion”
➤ 38% of LAD occlusions (TIMI 0) are missed by standard ECG criteria
➤ AI detected 100% of occlusions on the first ECG
➤ Missed LAD occlusion patients had a median delay to treatment of 492 minutes

3️⃣ “AI detection of occlusion in ST-elevation aVR patients”
➤ Traditional interpretation fails in complex cases like STE in aVR
➤ Queen of Hearts AI model achieved 100% sensitivity for ACO detection

30/06/2025

Alphaiota and Powerful Medical have officially expanded their strategic partnership to launch , the first AI-powered heart attack diagnostic platform, in the Kingdom of Saudi Arabia.

PMcardio, clinically validated and trusted by over 100,000 healthcare professionals worldwide, detects 39 cardiac conditions from a standard 12-lead ECG — identifying acute heart attacks up to 3 hours earlier and with twice the sensitivity of current practice.

With as the exclusive regional distributor, this milestone supports Saudi Arabia’s Vision 2030 by localizing high-impact technologies that advance digital health and improve outcomes in emergency cardiac care.

This partnership marks the first deployment of PMcardio in the Middle East, helping position Saudi Arabia as a regional leader in AI-driven healthcare innovation.

26/06/2025

We’re proud to share that Powerful Medical has been awarded a €1M grant by the Slovak Ministry of Economy, funded through the EU Recovery and Resilience Plan.

The grant will support the development of our newest OMI AI ECG model, advancing the early detection of heart attacks that are often missed by current diagnostic methods. The project focuses on improving diagnostic accuracy and speed while reducing treatment time by up to 3.7 hours.

This investment strengthens Slovakia’s role in European health tech innovation and supports the development of next-generation diagnostic capabilities within our CE-certified platform, .

25/06/2025

Our Chief Medical Officer, Robert Herman, MD, PhD, will be speaking at the Masterclass in AI and Cardiovascular Health, organized by the European Society of Cardiology, taking place in Amsterdam.

His presentation, titled “How to build an AI spin-off: a real-world example,” is part of the session “Journey of a medical startup using ECG-AI.” It will take place on Saturday, 28 June, from 12:00 to 13:00 at Kimpton De Witt Amsterdam.

Dr. Herman will share practical insights into the development of an AI-powered medical startup, including clinical integration and lessons learned from translating ECG-AI from research into real-world clinical use.

Join this session if you're a healthcare professional, researcher, or innovator interested in how artificial intelligence is being applied in real-world cardiovascular care.

11/06/2025

Join us at Belvis- The Belgrade Valve International Symposium 2025 in Belgrade, Serbia, this Saturday, where our Chief Medical Officer, Robert Herman, MD, PhD, will give a presentation on:

"OMI vs NOMI Concept and the Role of AI in ECG Interpretation"
14 June 2025 | 8:30–9:45

Dr. Herman will discuss how rethinking the classic STEMI/NSTEMI paradigm in favor of the OMI/NOMI model is transforming the chest pain pathway. Early identification of Occlusion Myocardial Infarction (OMI)—regardless of ST-elevation—is essential to reduce time to reperfusion and preserve myocardium.

He will explore how AI-powered tools like support this approach by streamlining ECG interpretation and triage at the point of care.

If you're attending , don’t miss this session on advancing acute MI diagnostics!

06/06/2025

We’re proud to share that Powerful Medical has been selected to join the 2025 MedTech Innovator Cohort in the Cardiovascular & Interventional category!

Chosen from over 1,400 global applicants, this recognition highlights our commitment to redefining cardiovascular care through AI-driven diagnostics.

Built for the realities of acute care, our diagnostic and care coordination platform, , equips clinicians with instant ECG interpretation to detect STEMI and STEMI equivalents earlier and more accurately, especially in high-pressure emergency settings. The goal: eliminate delays in diagnosis, accelerate access to intervention, and give every cardiac patient a better chance at survival.

We’re excited to be part of this global community of innovators and to continue advancing healthcare through cutting-edge technology.

02/06/2025

Study Milestone Reached: All 9 Sites Activated for the AI-ECG TIMI Study

We’re excited to share that the final two sites—LKH Graz II - Standort West (under PI: Dr. Martin Genger) and LKH Standort-Bruck (under PI: Dr. Gert Klug)—have now received ethics committee approval. With all 9/9 participating centers across Austria, Belgium, and Italy now active, the AI-ECG TIMI Study is fully operational.

This marks a major operational milestone in our international AI-ECG TIMI Study, focused on validating AI-driven ECG interpretation for acute coronary syndromes in real-world settings.

With all sites now live, we’re fully set to move forward with:

‣ 700+ patient enrollments
‣ Cross-country data harmonization
‣ Evidence generation that bridges clinical gaps in ACS diagnostics

Stay tuned for more updates soon.

30/05/2025

We're excited to be heading to Zurich for the SSC/SSCS Annual Meeting 2025, taking place from 4–6 June and hosted by the Swiss Society of Cardiology and the Swiss Society of Cardiac Surgery!

We’ll be showcasing how – our AI-powered ECG diagnostics and care coordination platform – drives smarter, faster decision-making in cardiac care, supporting clinicians from first point-of-contact triage to in-hospital workflows.

Explore our latest features, including advanced STEMI and STEMI-equivalent detection, built-in explainability to support clinical confidence, improved usability, and seamless integration for both individual practitioners and healthcare systems.

Visit us at the PMcardio booth (N04) to see our technology in action and learn how it can support your clinical practice.

22/05/2025

Live from EuroPCR 2025 in Paris!

It’s been a pleasure connecting with the cardiology community to explore how AI can enhance clinical decision-making in acute cardiac care. We’re showcasing advancements in AI-powered ECG interpretation, with the PMcardio STEMI AI ECG Model—developed to detect both STEMI and STEMI-equivalents with high precision, enabling faster and more confident triage.

These capabilities are part of our PMcardio solutions for both individual clinicians and healthcare organisations, designed to support clinical teams across the entire chest-pain patient pathway.

Visit us at Booth M42 to experience it firsthand and join the conversation.

20/05/2025

A New Era in AI-Powered Second Opinions for ECG Interpretation

We’re proud to introduce PMcardio for Individuals 3.0, delivering instant, explainable AI support for ECG interpretation—empowering faster, more confident decision-making in acute cardiovascular care.

Whether you’re working in a hub hospital, spoke clinic, or remote medical center, PMcardio 3.0 provides immediate diagnostic clarity—supporting earlier recognition of STEMI and STEMI-equivalents (OMIs) and enabling timely triage and referral for life-saving interventions.

Key innovations in PMcardio 3.0:

• Queen of Hearts™ — Our most advanced STEMI detection model yet, built to identify both typical and atypical occlusive myocardial infarctions using a globally diverse dataset

• ECGxplain™ — Lead-by-lead heatmaps that provide transparent, explainable AI interpretation, improving trust and supporting clinical education

• Automated ECG digitization — Instantly recognizes and processes ECGs from any format—paper printouts, photos, or digital screenshots—no manual input required

• Backed by robust clinical validation — Independently validated in 19 international clinical studies, consistently showing superior diagnostic accuracy and early OMI detection

Trusted Features, Now Even Better:
• Unlimited ECG analyses
• Advanced diagnostic support and insights
• Detailed ECG report history
• Confidence indicators to flag complex cases for deeper review

Start using PMcardio today—download the app here: https://eu1.hubs.ly/H0kd2840

Try it out with free access, including 5 ECG analyses per month—perfect for exploring how fast and accurate AI-powered interpretation can enhance your clinical decision-making. When you're ready for full functionality, upgrade to the Pro Plan.

15/05/2025

We are excited to be attending EuroPCR 2025 in Paris!

From May 20–23, we look forward to showcasing the latest advancements in AI-powered cardiac diagnostics, including the PMcardio STEMI AI ECG Model, designed to detect both STEMI and STEMI-equivalents with precision—supporting faster, more confident triage and treatment decisions.

We’ll be demonstrating PMcardio for Organisations, our care coordination platform built to integrate seamlessly into health systems, alongside the new PMcardio for Individuals, now equipped with a range of updated features tailored to the needs of clinicians in everyday practice.

Visit us at Booth M42 to explore how our solutions can support your clinical workflows.
Stay tuned—more details on our scientific presentations are coming soon.

Powerful Medical

01/08/2025

29/07/2025

30/06/2025

26/06/2025

25/06/2025

11/06/2025

06/06/2025

02/06/2025

30/05/2025

22/05/2025

20/05/2025

15/05/2025

Address

Website

Alerts

Contact The Practice

Shortcuts

Share

Category